EFFECT OF BIVALIRUDIN VERSUS HEPARIN IN A CONTEMPORARY TAVR POPULATION OF WOMEN: RESULTS FROM THE BRAVO 3 RANDOMIZED TRIAL

Jaya Chandrasekhar,Anna Petronio,Thierry Lefèvre,Christian Kupatt, D. Tchetche,Nicolas Dumonteil,John Webb,Antonio Colombo, Stephan Windecker,David Hildick-Smith,Peter Boekstegers,Axel Linke, Eric Van Belle,Gennaro Sardella,Oliver Husser,Eberhard Grube,Efthymios Deliargyris,Promodoros Anthopoulos, Roxana Mehran, George Dangas

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY（2016）

引用 0|浏览16

暂无评分

摘要

Women experience greater bleeding and vascular complications in transcatheter aortic valve replacement (TAVR). Whether bivalirudin lowers bleeding risk in women compared with unfractionated heparin (UFH) is unknown.BRAVO 3 was a randomized multicenter trial comparing transfemoral TAVR with

查看译文

关键词

heparin,bivalirudin,contemporary tavr population

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要